CLOs on the Move

Guerbet

www.guerbet.com

 
Guerbet is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.guerbet.com
  • 1185 W 2nd St
    Bloomington, IN USA 47403
  • Phone: 812.333.0059

Executives

Name Title Contact Details

Similar Companies

GlySens

GlySens Incorporated is a privately held corporation devoted to developing the world`s first truly long term continuous glucose monitoring system. Our goal: to enable easy, unobtrusive, worry-free diabetes control that empowers users by providing the information they need to optimize care, while freeing them to live life on their own terms.

Instrumentation Laboratory

Instrumentation Laboratory is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oasis Lifestyle

Oasis Manufactures whirlpools, soaking tubs and shower stalls. We have been in business for over twenty years. At Oasis we strive to ensure quality and value in our whirlpool baths and systems. We study the current trends and market needs to stay at the

Sightech Vision Systems

Sightech Vision Systems is a Santa Clara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iSpecimen

Headquartered in Lexington, MA, iSpecimen offers an online marketplace for the purchase of human biospecimens, providing researchers with the specimens they need from the patients they want. The iSpecimen Marketplace connects healthcare organizations that have access to patients and specimens with the scientists who need them for their research and development projects. Proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. Researchers easily and compliantly gain access to specimens to drive scientific discovery. Partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. And ultimately, healthcare advances for all.